In the tumor microenvironment, the expression of PD-L1 can be markedly upregulated on tumor cells in the presence of interferon-gamma (IFN-γ), while the expression of PD-1 is significantly lifted on tumor-infiltrating lymphocytes. The gene discussed is IFNG; the disease is neoplasm.